RAC1 and hepatocellular carcinoma: As expected, both the loss-of-function and gain-of-function cellular model showed that MG53 significantly inhibited the capabilities of proliferation, colony formation and migration of HCC cells, and further investigation demonstrated that the anti-tumor effect of MG53 was mediated through its negative regulation of RAC1 activity.